D-0045-2027 Class II Ongoing

Recalled by Ascend Laboratories, LLC — Bedminster, NJ

FDA drug recall D-0045-2027 was initiated by Ascend Laboratories, LLC on Oct 6, 2026 and is designated Class II. Reason for recall: Out of specification due to dissolution. The recall status is ongoing. Affected quantity: 11,424 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 28, 2026
Initiation Date
Oct 6, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
11,424 bottles.

Product description

Amlodipine and Olmesartan Medoxomil Tablets, 10mg/40mg, 30 Tablets, Rx only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-502-30.

Reason for recall

Out of specification due to dissolution.

Distribution pattern

Nationwide within the United States

Code information

Lot # 25120696, Exp Date: December 31, 2026.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0045-2027
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0045-2027. Report a data issue: hello@regdatalab.com.